35 TMAO was locally injected into four major anterior right GP and increased neural activity and the susceptibility of atrial to AF through changing the atrial electrophysiological properties by activating p65 NF-B signaling pathway resulting in the expression of inflammatory cytokines, which may induce atrial rhythm disorders
Results showed that GLP-1 receptor agonists and SGLT2 inhibitors were superior in reducing the risk of MACE when compared to DPP-4 inhibitors (HR 086 [082089] and 086 [082090], respectively), but no difference was found between SGLT2 inhibitors and GLP-1 receptor agonists in reducing rate of MACE (HR of 101 (094107)) ( Conclusion In conclusion, CVOTs have played a pivotal role in evaluating the cardiovascular safety and efficacy of GLP-1 receptor agonists in patients with T2D
However, this association was not found in another human genetic study (Tsermpini et al., 2022)
Kang MG, Han SW, Kang HR, Hong SJ, Kim DH, Choi JH
Figure 4 shows the principle of how the vaccine vector is constructed